We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
CerTest Biotec, along with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the VIASURE SARS-CoV-2 (N1 + N2) Real Time PCR
UK-based medical device manufacturer LivaNova and Verily, a subsidiary of Alphabet, have enrolled the first patient in their collaborative study UNCOVER. UNCOVER is an opt-in research study for
Mediso Medical Imaging Systems today announced that it has completed the technology transfer of the new Cameleon4™ MRI spectrometer developed by RS2D (Strasbourg, France). Following the IP transfer,
Peijia Medical has received approval for commercialisation from China’s National Medical Products Administration (NMPA) for its TaurusOne Transcatheter Aortic Valve Replacement (TAVR) System. The China-based medical technology company
Ekso Bionics, an industry leader in exoskeleton technology, with presence in Hong Kong, announces its partnership with Royal Rehab in Australia, further scaling the use of its robotic
US-based remote care management firm Current Health has secured $43m in a Series B financing round led by Northpond Ventures. LRVHealth, OSF HealthCare, Section 32, Elements Health Ventures,
DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the launch of DermTech PLAplusTM, its next generation test
Medtronic has received the US Food and Drug Administration (FDA) approval for Pipeline Flex embolisation device with Shield Technology. Shield Technology is developed to advance flow diversion therapy
Hillrom has launched its new Welch Allyn PanOptic Plus Ophthalmoscope and the Welch Allyn MacroView Plus Otoscope devices for physical assessment. According to the company, examining the eyes
BioStable Science & Engineering, Inc. (“BioStable”) announced today the company has received CE Mark approval for the HAART 200 Aortic Annuloplasty Device for use during bicuspid aortic valve